Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Advanced Solid Tumors 40Advanced Solid Tumor 24Solid Tumors 23Mesothelioma, Malignant 14Mesothelioma 14Solid Tumor 12Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 8Malignant Solid Neoplasm 7Pancreatic Neoplasms 6Solid Tumours 5Solid Tumor, Adult 5Neoplasms 5Colorectal Neoplasms 5Stomach Neoplasms 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Triple Negative Breast Neoplasms 3Sarcoma 3Retinoblastoma 3Kidney Neoplasms 3Advanced or Metastatic Solid Tumors 3Advanced Malignant Solid Tumors 3Advanced Malignant Solid Neoplasm 3Thymoma 2Solitary Fibrous Tumor, Pleural 2Solid Tumor Malignancies 2Solid Tumor Cancer 2Small Cell Lung Carcinoma 2

Interventions

pembrolizumab 1cediranib 1Platinum 1Pharmacogenomic Testing 1Pemetrexed 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solitary Fibrous Tumor, Pleural × Other solid neoplasm × 30 days × Clear all
NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
117 enrolled 23 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT02399371 2026-05-08

Pembrolizumab in Treating Patients With Malignant Mesothelioma

University of Chicago

Phase 2 Completed
65 enrolled 12 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡